ID

26273

Descripción

Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 Ongoing Record: Other (Non-Study) Medication

Palabras clave

Versiones (1)
  1. 15/10/17 15/10/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

15 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC-ND 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Concomitant Medication Ropinirole in Parkinson's Disease GSK 101468/196

Inglés

Concomitant Medication Ropinirole in Parkinson's Disease GSK 101468/196

1 formularios  
Patient Information
Descripción

Patient Information

Alias
UMLS CUI-1
C1955348
Patient No.
Descripción

Patient Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1830427
Other (Non-Study) Medications
Descripción

Other (Non-Study) Medications

Alias
UMLS CUI-1
C2347852
Has the patient taken any concomitant medication(s) (other than study drug) from the Re-Enrollment Screening Visit through the end of the Treatment Period? This CRF will only be used by subjects who have re-enrolled in the study after completion at 36 months.
Descripción

Concomitant Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
Medication (Use Generic Name)
Descripción

Medication Name

Tipo de datos

text

Alias
UMLS CUI [1]
C2360065
Date started
Descripción

Start Date

Tipo de datos

date

Unidades de medida
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C0808070
dd-mmm-yyyy
Date stopped
Descripción

End Date

Tipo de datos

date

Unidades de medida
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C0806020
dd-mmm-yyyy
Continuing
Descripción

Ongoing Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826666
Dose (e.g. 10 mg)
Descripción

Dosage

Tipo de datos

text

Alias
UMLS CUI [1]
C0178602
Frequency (e.g. tid)
Descripción

Medication Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

Administration Route

Tipo de datos

text

Route: If Other, Specify:
Descripción

Administration Route: Specification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C2348235
Indication
Descripción

Indication

Tipo de datos

text

Alias
UMLS CUI [1]
C3146298
Volver a la parte superior de la página

Similar models

Concomitant Medication Ropinirole in Parkinson's Disease GSK 101468/196

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient No.
text
C1830427 (UMLS CUI [1])
Item Group
Other (Non-Study) Medications
C2347852 (UMLS CUI-1)
Concomitant Medication
Item
Has the patient taken any concomitant medication(s) (other than study drug) from the Re-Enrollment Screening Visit through the end of the Treatment Period? This CRF will only be used by subjects who have re-enrolled in the study after completion at 36 months.
boolean
C2347852 (UMLS CUI [1])
Medication Name
Item
Medication (Use Generic Name)
text
C2360065 (UMLS CUI [1])
Start Date
Item
Date started
date
C0808070 (UMLS CUI [1])
End Date
Item
Date stopped
date
C0806020 (UMLS CUI [1])
Ongoing Medication
Item
Continuing
boolean
C2826666 (UMLS CUI [1])
Dosage
Item
Dose (e.g. 10 mg)
text
C0178602 (UMLS CUI [1])
Medication Frequency
Item
Frequency (e.g. tid)
text
C3476109 (UMLS CUI [1])
Item
Route
text
Administration Route
Code List
Route
CL Item
IV (IV)
CL Item
IM (IM)
CL Item
PO (PO)
CL Item
SC (SC)
CL Item
PR (PR)
CL Item
Sublingual (Sublingual)
CL Item
Inhaled (Inhaled)
CL Item
Topical (Topical)
CL Item
Other (Other)
Item
Route: If Other, Specify:
text
C0013153 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Administration Route
Code List
Route: If Other, Specify:
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial